BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou X, Chen Z. Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Arch Pharm Res 2015;38:2193-200. [PMID: 26152876 DOI: 10.1007/s12272-015-0630-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Eita AS, M. A. Makky A, Anter A, Khalil IA. Repurposing of atorvastatin emulsomes as a topical antifungal agent. Drug Delivery 2022;29:3414-3431. [DOI: 10.1080/10717544.2022.2149898] [Reference Citation Analysis]
2 Alharbi WS, Hareeri RH, Bazuhair M, Alfaleh MA, Alhakamy NA, Fahmy UA, Alamoudi AA, Badr-Eldin SM, Ahmed OA, AlGhamdi SA, Naguib MJ. Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment. Pharmaceutics 2022;14. [PMID: 36559120 DOI: 10.3390/pharmaceutics14122627] [Reference Citation Analysis]
3 Eita AS, Makky AM, Anter A, Khalil IA. Atorvastatin-loaded emulsomes foam as a topical antifungal formulation. International Journal of Pharmaceutics: X 2022. [DOI: 10.1016/j.ijpx.2022.100140] [Reference Citation Analysis]
4 Abbas H, Gad HA, El Sayed NS, Rashed LA, Khattab MA, Noor AO, Zewail M. Development and Evaluation of Novel Leflunomide SPION Bioemulsomes for the Intra-Articular Treatment of Arthritis. Pharmaceutics 2022;14:2005. [DOI: 10.3390/pharmaceutics14102005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Badr-Eldin SM, Aldawsari HM, Fahmy UA, Ahmed OAA, Alhakamy NA, Al-Hejaili OD, Alhassan AA, Ammari GA, Alhazmi SI, Alawadi RM, Bakhaidar R, Alamoudi AJ, Neamatallah T, Tima S. Optimized Apamin-Mediated Nano-Lipidic Carrier Potentially Enhances the Cytotoxicity of Ellagic Acid against Human Breast Cancer Cells. Int J Mol Sci 2022;23:9440. [PMID: 36012704 DOI: 10.3390/ijms23169440] [Reference Citation Analysis]
6 Aldawsari HM, Badr-Eldin SM, Assiri NY, Alhakamy NA, Privitera A, Caraci F, Caruso G. Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route: in vitro optimization and in vivo pharmacokinetic assessment. Drug Deliv 2022;29:2671-84. [PMID: 35975309 DOI: 10.1080/10717544.2022.2110996] [Reference Citation Analysis]
7 Abo El-enin HA, Mostafa RE, Ahmed MF, Naguib IA, A. Abdelgawad M, Ghoneim MM, Abdou EM. Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms. Pharmaceutics 2022;14:410. [DOI: 10.3390/pharmaceutics14020410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Alhakamy NA, Fahmy UA, Eldin SMB, Ahmed OAA, Aldawsari HM, Okbazghi SZ, Alfaleh MA, Abdulaal WH, Alamoudi AJ, Mady FM. Scorpion Venom-Functionalized Quercetin Phytosomes for Breast Cancer Management: In Vitro Response Surface Optimization and Anticancer Activity against MCF-7 Cells. Polymers (Basel) 2021;14:93. [PMID: 35012116 DOI: 10.3390/polym14010093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 El-Zaafarany GM, Nasr M. Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases. Pharm Dev Technol 2021;26:1136-57. [PMID: 34751091 DOI: 10.1080/10837450.2021.2004606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Elsheikh MA, Rizk SA, Elnaggar YSR, Abdallah OY. Nanoemulsomes for Enhanced Oral Bioavailability of the Anticancer Phytochemical Andrographolide: Characterization and Pharmacokinetics. AAPS PharmSciTech 2021;22:246. [PMID: 34617166 DOI: 10.1208/s12249-021-02112-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rizk SA, Elsheikh MA, Elnaggar YS, Abdallah OY. Novel bioemulsomes for baicalin oral lymphatic targeting: development, optimization and pharmacokinetics. Nanomedicine (Lond) 2021;16:1983-98. [PMID: 34420422 DOI: 10.2217/nnm-2021-0137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Aldawsari HM, Ahmed OAA, Alhakamy NA, Neamatallah T, Fahmy UA, Badr-Eldin SM. Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment. Pharmaceutics 2021;13:783. [PMID: 34073780 DOI: 10.3390/pharmaceutics13060783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
13 Tvrdý V, Pourová J, Jirkovský E, Křen V, Valentová K, Mladěnka P. Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev 2021;41:2195-246. [PMID: 33587317 DOI: 10.1002/med.21791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Fereig SA, El-Zaafarany GM, Arafa MG, Abdel-Mottaleb MMA. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis. Drug Deliv 2020;27:662-80. [PMID: 32393082 DOI: 10.1080/10717544.2020.1754527] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
15 Wu W, Wang L, Wang S. Amorphous silibinin nanoparticles loaded into porous starch to enhance remarkably its solubility and bioavailability in vivo. Colloids Surf B Biointerfaces 2021;198:111474. [PMID: 33257158 DOI: 10.1016/j.colsurfb.2020.111474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Imani M, Dehghan A. Leishmaniasis. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment 2020. [DOI: 10.1002/9781119671732.ch15] [Reference Citation Analysis]
17 Awan ZA, Fahmy UA, Badr-Eldin SM, Ibrahim TS, Asfour HZ, Al-Rabia MW, Alfarsi A, Alhakamy NA, Abdulaal WH, Al Sadoun H, Helmi N, Noor AO, Caraci F, Almasri DM, Caruso G. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells. Pharmaceutics 2020;12:E597. [PMID: 32604984 DOI: 10.3390/pharmaceutics12070597] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
18 Martins AM, Ascenso A, Ribeiro HM, Marto J. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs. Mol Neurobiol 2020;57:2391-419. [DOI: 10.1007/s12035-020-01889-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
19 Joseph SK, Sabitha M, Nair SC. Stimuli-Responsive Polymeric Nanosystem for Colon Specific Drug Delivery. Adv Pharm Bull 2020;10:1-12. [PMID: 32002356 DOI: 10.15171/apb.2020.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
20 Takke A, Shende P. Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomedicine: Nanotechnology, Biology and Medicine 2019;21:102057. [DOI: 10.1016/j.nano.2019.102057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
21 Di Costanzo A, Angelico R. Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art. Molecules 2019;24:E2155. [PMID: 31181687 DOI: 10.3390/molecules24112155] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 15.3] [Reference Citation Analysis]
22 Hossainzadeh S, Ranji N, Naderi Sohi A, Najafi F. Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR-125b/miR-182 in human breast cancer cells. J Cell Physiol 2019;234:22285-98. [PMID: 31073992 DOI: 10.1002/jcp.28795] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
23 Solís-gómez A, Sato-berrú R, Mata-zamora M, Saniger J, Guirado-lópez R. Characterizing the properties of anticancer silibinin and silybin B complexes with UV–Vis, FT-IR, and Raman spectroscopies: A combined experimental and theoretical study. Journal of Molecular Structure 2019;1182:109-18. [DOI: 10.1016/j.molstruc.2019.01.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Murphy EC, Schaffter SW, Friedman AJ. Nanotechnology for Psoriasis Therapy. Curr Derm Rep 2019;8:14-25. [DOI: 10.1007/s13671-019-0248-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
25 Al-obaidy SS, Greenway GM, Paunov VN. Dual-functionalised shellac nanocarriers give a super-boost of the antimicrobial action of berberine. Nanoscale Adv 2019;1:858-72. [DOI: 10.1039/c8na00121a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
26 Al-obaidy SSM, Halbus AF, Greenway GM, Paunov VN. Boosting the antimicrobial action of vancomycin formulated in shellac nanoparticles of dual-surface functionality. J Mater Chem B 2019;7:3119-33. [DOI: 10.1039/c8tb03102a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
27 El-Zaafarany GM, Soliman ME, Mansour S, Cespi M, Palmieri GF, Illum L, Casettari L, Awad GAS. A Tailored Thermosensitive PLGA-PEG-PLGA/Emulsomes Composite for Enhanced Oxcarbazepine Brain Delivery via the Nasal Route. Pharmaceutics 2018;10:E217. [PMID: 30400577 DOI: 10.3390/pharmaceutics10040217] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
28 Ma Y, He H, Xia F, Li Y, Lu Y, Chen D, Qi J, Lu Y, Zhang W, Wu W. In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability. Nanomedicine 2017;13:2643-54. [PMID: 28778838 DOI: 10.1016/j.nano.2017.07.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
29 Chávez G, Campos CH, Jiménez VA, Torres CC, Díaz C, Salas G, Guzmán L, Alderete JB. Polyamido amine (PAMAM)-grafted magnetic nanotubes as emerging platforms for the delivery and sustained release of silibinin. J Mater Sci 2017;52:9269-81. [DOI: 10.1007/s10853-017-1140-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
30 Diaz C, Guzmán J, Jiménez VA, Alderete JB. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin. Pharmaceutical Development and Technology 2017;23:689-96. [DOI: 10.1080/10837450.2017.1315134] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
31 Alavi M, Karimi N, Safaei M. Application of Various Types of Liposomes in Drug Delivery Systems. Adv Pharm Bull 2017;7:3-9. [PMID: 28507932 DOI: 10.15171/apb.2017.002] [Cited by in Crossref: 210] [Cited by in F6Publishing: 216] [Article Influence: 35.0] [Reference Citation Analysis]